Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study
Abstract Background The serum creatinine-to-cystatin C ratio (Scr/Scys) has been suggested as a surrogate marker of muscle mass and a predictor of adverse outcomes in many diseases. However, the prognostic value of Scr/Scys in patients with type 2 diabetes mellitus (T2DM) is unknown. The aim of this...
Main Authors: | Wen Wei, Shanggang Li, Jin Liu, Yong Liu, Kaihong Chen, Shiqun Chen, Mei Tu, Hong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13098-022-00958-y |
Similar Items
-
Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
by: Shanshan Shi, et al.
Published: (2022-08-01) -
Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
by: Chan‐Young Jung, et al.
Published: (2022-08-01) -
Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01) -
Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
by: Shunhui Gao, et al.
Published: (2023-06-01) -
Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
by: Young Youl Hyun, et al.
Published: (2022-09-01)